Literature DB >> 8188341

Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae.

R L Deresiewicz1, J A Flaxenburg, M Chan, R W Finberg, D L Kasper.   

Abstract

In order to search for an occult cytotoxic enzymatic activity of the toxic shock syndrome toxin 1 (TSST-1), we placed the gene encoding TSST-1 (tstH) under the control of an inducible promoter in the eukaryotic yeast Saccharomyces cerevisiae. Under similar circumstances, the known bacterial enzymatic cytotoxins Shiga-like toxin and diphtheria toxin are both highly lethal to the yeast host. Although full-length stable TSST-1 was demonstrated within the yeast cells and although it retained mitogenicity for human T cells, it had no apparent effect on the yeast cells' growth kinetics or on their gross morphology. Retrieval and sequencing of the toxin gene revealed the wild-type sequence throughout, thus demonstrating that the apparent lack of toxicity for the yeast cells was not due to a serendipitous attenuating mutation within the coding region of the toxin gene. Similar results obtained after a second transformation of the same strain and after transformation of an unrelated strain demonstrate that neither chance permissive host mutation nor intrinsic host resistance was likely to have obscured an existing cytotoxic property of TSST-1. We conclude that TSST-1 probably does not possess a discrete enzymatic property cytotoxic for eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188341      PMCID: PMC186498          DOI: 10.1128/iai.62.6.2202-2207.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Mediators in the pathogenesis of toxic shock syndrome: overview.

Authors:  J Parsonnet
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

Review 2.  Diphtheria toxin: mode of action and structure.

Authors:  R J Collier
Journal:  Bacteriol Rev       Date:  1975-03

3.  Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae.

Authors:  A Frankel; D Schlossman; P Welsh; A Hertler; D Withers; S Johnston
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

4.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

5.  The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1.

Authors:  D A Blomster-Hautamaa; B N Kreiswirth; J S Kornblum; R P Novick; P M Schlievert
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

6.  Staphylococcal toxic shock toxin specifically binds to cultured human epithelial cells and is rapidly internalized.

Authors:  V M Kushnaryov; H S MacDonald; R Reiser; M S Bergdoll
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Study of staphylococcal toxic shock syndrome toxin in human epithelial cell culture.

Authors:  V M Kushnaryov; M S Bergdoll; H S MacDonald; J Vellinga; R Reiser
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

8.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

9.  The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family.

Authors:  H Fu; J Coburn; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  Damaging effect of toxic shock syndrome toxin 1 on chick embryo cells in vitro.

Authors:  A Drumm; J C de Azavedo; J P Arbuthnott
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb
View more
  2 in total

1.  Expression of bacterial superantigen genes in mice induces localized mononuclear cell inflammatory responses.

Authors:  S W Dow; T A Potter
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

2.  A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.

Authors:  P F Bonventre; H Heeg; C K Edwards; C M Cullen
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.